An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
Tomorrow PIPC Chairman Tony Coelho will participate in a panel discussion on comparative effectiveness research (CER) here in Washington, DC. With Congress back in session and healthcare reform taking center stage, PIPC is continuing to engage Members of Congress about the importance of patient-centered CER.
PIPC supports good CER. We all agree that research should be done to see what types of treatments work and that information should be readily accessible to doctors and patients. And this information should be used to expand choices for patients, not limit them. That’s why we are working so hard to make sure that Congress passes patient-centered CER.
Just last week, Senate Finance Chairman Max Baucus submitted his healthcare reform proposal and in it were strong CER provisions. In discussing the proposal, PIPC Chairman Coelho said, “Sen. Baucus’s measure creates an independent Institute governed by patients, providers, government officials and other stakeholders, and further strengthens safeguards to protect patient access to the treatment options they need. This provides a sound framework for independent, sustained, and objective research that is focused on the needs of patients.”